Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

This activity, COPE Activity Number 123086, is accredited by COPE for continuing education for optometrists.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Dompé.

Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis

Release Date: December 20, 2021
Expiration Date: December 20, 2022

Activity Overview

This video-based program is designed for health care professionals to explore the diagnosis and treatment of neurotropic keratitis (NK) through a unique perspective, putting the patient voice front and center. A patient with NK will share her experiences. Expert faculty will share commentary on NK etiology, pathogenesis, clinical presentation, diagnostic approach, efficacy and safety data of available therapies, and best practices for treatment of NK.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Dompé.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This online educational activity is directed towards general ophthalmologists and optometrists. Additional clinicians who may have the opportunity to diagnosis patients with neurotrophic keratitis will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Describe the dysfunction of corneal sensory innervation that leads to NK, as compared to normal function
Apply testing strategies that provide prompt diagnosis and disease classification for patients with NK
Develop optimal treatment approaches for patients with NK that are individualized for their disease stage
Assess the effects of NK on patients’ quality of life

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.

Faculty

Francis S. Mah, MD
Director, Cornea Service
Co-Director, Refractive Surgery Service
Division of Ophthalmology
Department of Surgery
Scripps Clinic
La Jolla, CA

Disclosures: Grant/Research Support: Allergan; Consultant: Allergan, Novartis, Sun, Kala Pharmaceuticals, Johnson & Johnson, Alcon, Dompé; Stock/Shareholder: Ocular Science.

Karolinne Rocha, MD, PhD
Director, Cornea and Refractive Surgery Division
Associate Professor of Ophthalmology
Director Cornea & Refractive Surgery Fellowship Director
Medical University of South Carolina
Storm Eye Institute
Charleston, SC

Disclosures: Consultant: Dompé.

Patricia Harty
Patient

Disclosures: Patricia Harty has no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.